Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis

KA Staats, DR Borchelt, MG Tansey… - Molecular …, 2022‏ - Springer
Abstract Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in
which many processes are detected including (neuro) inflammation. Many drugs have been …

Inflammatory checkpoints in amyotrophic lateral sclerosis: from biomarkers to therapeutic targets

Z Jiang, Z Wang, X Wei, XF Yu - Frontiers in Immunology, 2022‏ - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive motor neuron damage. Due to the complexity of the ALS, so far the etiology and …

Diaphragmatic neurophysiology and respiratory markers in ALS

M De Carvalho, M Swash, S Pinto - Frontiers in neurology, 2019‏ - frontiersin.org
The main reason for short survival in amyotrophic lateral sclerosis (ALS) is involvement of
respiratory muscles. Severe compromise of diaphragmatic function due to marked loss of …

Interleukin-6 and amyotrophic lateral sclerosis

A Pronto-Laborinho, S Pinto, M Gromicho… - Journal of the …, 2019‏ - Elsevier
Background IL-6 is an inflammatory cytokine that is a possible factor in progression of the
disease. We have investigated venous blood levels of IL-6 in controls and ALS patients in …

Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis

T Koch, R Fabian, L Weinhold, FW Koch… - Annals of Clinical …, 2024‏ - Wiley Online Library
Objective Informative biomarkers are an urgent need in the management of amyotrophic
lateral sclerosis. Serum cardiac troponin T is elevated in the majority of amyotrophic lateral …

Estudio sobre biomarcadores moleculares para el diagnóstico y el seguimiento de esclerosis lateral amiotrófica.

C Fornés Pérez - Therapeía, 2019‏ - riucv.ucv.es
La esclerosis lateral amiotrófica o ELA es una enfermedad neurodegenerativa
caracterizada por una degradación gradual de la función de las motoneuronas, lo que …

Biomarcadores respiratórios na abordagem clínica da Esclerose Lateral Amiotrófica

ACO de Oliveira - 2020‏ - search.proquest.com
Abstract A Esclerose Lateral Amiotrófica (ELA) é uma doença neurodegenerativa de
progressão rápida e fatal, caracterizada pela rápida destruição dos neurónios motores …

Estudio sobre biomarcadores moleculares para el diagnóstico y el seguimiento de ELA

C Fornés Pérez - 2019‏ - riucv.ucv.es
La esclerosis lateral amiotrófica o ELA es una enfermedad neurodegenerativa
caracterizada por una degradación gradual de la función de las motoneuronas provocando …

[معلومات الإصدار][C] Creatinina, um biomarcador de prognóstico e preditor da função respiratória na Esclerose Lateral Amiotrófica

JAM Martins - 2019